Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.

Infectious diseases and therapy·2022
Same author

Epidemiological and clinical characteristics of HIV infection in the Spanish VACH Cohort: a descriptive study.

Epidemiologia e prevenzione·2022
Same author

Assessment of Drug Interactions with Online Electronic Checkers in Multi-Pathological Patients.

Pharmacology·2021
Same author

eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort.

HIV research & clinical practice·2021
Same author

Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.

PloS one·2021
Same author

Factors Associated with Nonsuppression of HIV Infection in the Spanish VACH Cohort.

AIDS research and human retroviruses·2020
Same journal

Systematic review and meta-analysis of risk prediction models for HIV testing in key populations.

AIDS reviews·2026
Same journal

Hantavirus outbreak in a cruise departing from Argentina.

AIDS reviews·2026
Same journal

Dolutegravir shows efficacy in HTLV-1 infection.

AIDS reviews·2026
Same journal

Global research landscape of two-drug regimens for HIV treatment: a visual bibliometric analysis.

AIDS reviews·2026
Same journal

Antiretroviral therapy "à la carte".

AIDS reviews·2026
Same journal

Can Google <i>DeepMind</i> unlock the mystery of life's origin?

AIDS reviews·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Castleman's Disease. A Review.

Bernardino Roca1

  • 1Medicine and Infectious Disease Department, Hospital General of Castellon, University of Valencia, Valencia, Spain. brocav@meditex.es

AIDS Reviews
|March 18, 2009
PubMed
Summary
This summary is machine-generated.

Castleman's disease is a rare non-clonal lymph node hyperplasia with distinct pathological and clinical subtypes. Further research is needed to understand its causes and optimal treatments.

Related Experiment Videos

Last Updated: Jun 24, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Area of Science:

  • Oncology
  • Immunology
  • Pathology

Background:

  • Castleman's disease involves non-clonal lymph node hyperplasia.
  • Pathological subtypes include hyaline vascular, plasmacytic, and mixed cellularity.
  • Clinical presentations are unicentric (localized) or multicentric.

Purpose of the Study:

  • To review the characteristics of Castleman's disease.
  • To highlight the association with HIV infection.
  • To identify remaining uncertainties in etiopathogenesis and treatment.

Main Methods:

  • Literature review of Castleman's disease.
  • Analysis of pathological classifications.
  • Examination of clinical presentations.

Main Results:

  • Castleman's disease presents with diverse pathological and clinical features.
  • A notable association exists between Castleman's disease and HIV infection.
  • Etiopathogenesis and optimal treatment strategies require further elucidation.

Conclusions:

  • Castleman's disease is a complex lymphoproliferative disorder.
  • Understanding its subtypes and associations is crucial for patient management.
  • Further research is essential to address current knowledge gaps.